OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
11
Results
Show all
Save search
Copy query
Show results for
Unknown
(10)
Proteomics
(1)
Organisms
Escherichia coli
(1)
Repository
pride
(1)
Technology Type
Mass Spectrometry
(1)
Shotgun proteomics
(1)
Publication Date
2024
(1)
Release Date
2022
(2)
2020
(2)
2023
(1)
2021
(1)
2019
(1)
2018
(1)
2017
(1)
2015
(1)
Lab affiliation
Skolkovo Institute of Science and Technology, Moscow, Russia
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
CRISPR interference and priming varies with individual spacer sequences.
Not available
S-EPMC4678831
|
biostudies-literature
Cite
Primed CRISPR adaptation in Escherichia coli cells does not depend on conformational changes in the Cascade effector complex detected in Vitro.
Not available
S-EPMC5934681
|
biostudies-literature
Cite
Spacer-length DNA intermediates are associated with Cas1 in cells undergoing primed CRISPR adaptation.
Not available
S-EPMC5389516
|
biostudies-literature
Cite
Interaction between transcribing RNA polymerase and topoisomerase I prevents R-loop formation in E. coli.
Not available
S-EPMC9352719
|
biostudies-literature
Cite
Host nucleases generate prespacers for primed adaptation in the
E. coli
type I-E CRISPR-Cas system.
Not available
S-EPMC9699676
|
biostudies-literature
Cite
Prespacers formed during primed adaptation associate with the Cas1-Cas2 adaptation complex and the Cas3 interference nuclease-helicase.
Not available
S-EPMC8179228
|
biostudies-literature
Cite
Systematic analysis of Type I-E Escherichia coli CRISPR-Cas PAM sequences ability to promote interference and primed adaptation.
Not available
S-EPMC6568314
|
biostudies-literature
Cite
Characterization of CoCas9 nuclease from
Capnocytophaga ochracea
.
Not available
S-EPMC10521337
|
biostudies-literature
Cite
DNA targeting by Clostridium cellulolyticum CRISPR-Cas9 Type II-C system.
Not available
S-EPMC7038990
|
biostudies-literature
Cite
PpCas9 from Pasteurella pneumotropica - a compact Type II-C Cas9 ortholog active in human cells.
Not available
S-EPMC7708072
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets